trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Autoantibodies and autoimmune manifestations may occur in patients with hepatitis C.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
4 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that Autoantibodies and autoimmune manifestations may occur in patients with hepatitis C?

Yes. Clinical evidence consistently shows that chronic hepatitis C is frequently complicated by extrahepatic autoimmune manifestations, particularly mixed cryoglobulinemia and related immune disorders.

Verdict: SUPPORTED · 4 sources for, 0 against · Last checked

The analysis

The claim is specific and empirically testable, passing Step 0. The retrieved papers (0, 1, 4, 11) provide clear, well-documented evidence that hepatitis C virus infection triggers immune-mediated extrahepatic complications, including cryoglobulinemia and associated autoimmune phenomena. None of the papers refute the claim.

Evidence for · 4
Impact of Direct-Acting Antivirals on Extrahepatic Manifestations in Chronic Hepatitis C: A Narrative Review with a Hermeneutic Approach.
2025
Get citation
AAS, B., MD, I., RE, B., C, D., DS, R., V, B., SA, M. C., C, P., & L, B. (2025). Impact of Direct-Acting Antivirals on Extrahepatic Manifestations in Chronic Hepatitis C: A Narrative Review with a Hermeneutic Approach.. doi.org. https://doi.org/10.3390/healthcare13161953

See more details
More for · 3
Cryoglobulinemia, monoclonal and mixed cryoglobulinemia syndromes, cryoglobulinemic vasculitis: <i>a proposal for comprehensive nomenclature and definition</i>.
2026
Get citation
C, F., L, G., AL, Z., & D, G. (2026). Cryoglobulinemia, monoclonal and mixed cryoglobulinemia syndromes, cryoglobulinemic vasculitis: <i>a proposal for comprehensive nomenclature and definition</i>.. doi.org. https://doi.org/10.3389/fimmu.2026.1754012

Incidence and risk factors of extrahepatic manifestations in patients with chronic HCV and HCV/HIV infection
2022
Get citation
Dunaeva, N. V., Pervakova, M. Y., Mazing, A. S., & Lapin, S. V. (2022). Incidence and risk factors of extrahepatic manifestations in patients with chronic HCV and HCV/HIV infection. doi.org. https://doi.org/10.22328/2077-9828-2021-13-4-53-63

The Role of Direct-Acting Antivirals (DAAs) in Hepatitis C Virus-Associated Lymphoproliferative Disorders.
2026
Get citation
C, M., R, B., L, G., M, V., P, A., S, M., AL, Z., & V, G. (2026). The Role of Direct-Acting Antivirals (DAAs) in Hepatitis C Virus-Associated Lymphoproliferative Disorders.. doi.org. https://doi.org/10.3390/cancers18152501

What does the evidence say?

The claim is specific and empirically testable, passing Step 0. The retrieved papers (0, 1, 4, 11) provide clear, well-documented evidence that hepatitis C virus infection triggers immune-mediated extrahepatic complications, including cryoglobulinemia and associated autoimmune phenomena. None of the papers refute the claim.

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work